EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Reducing complexity in International Bladder Cancer Group intermediate‐risk non‐muscle‐invasive bladder cancer stratification: a three‐factor approach

Jayant Siva, Can Aydogdu iD, Nicholas Heller iD, Rishi Jonnalagadda, Patrick J Hensley, Gabriela M Diaz, Sean McSweeney, Rebecca Campbell, Nima Almassi, Reza Alaghehbandan, Christopher J Weight, Ashish M Kamat und 1 weitere

BJU International · 2026-08 · 138 (2) · 244-249

DOI: 10.1111/bju.70269 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift BJU International, online erschienen am 02.04.2026. Verfasst von Jayant Siva und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Cleveland Clinic, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate whether a simplified risk model preserves the prognostic performance of the International Bladder Cancer Group (IBCG) five‐factor risk stratification model in intermediate‐risk (IR) non‐muscle‐invasive bladder cancer (NMIBC). Patients and Methods We performed a multicentre retrospective analysis of 2822 patients with IR NMIBC treated with transurethral resection of bladder tumour and intravesical therapy between 2005 and 2025. Multivariable Cox regression identified independent predictors of recurrence and progression. A simplified risk model was constructed using significant variables and compared with the full IBCG model using recurrence and progression rates, area under the curve analysis, and likelihood ratio testing.

Results

A total of 2822 patients with IR NMIBC were included. When classified using the full IBCG model, 1143 (41%) were in the IR‐low, 1535 (54%) IR‐intermediate, and 144 (5%) IR‐high‐risk groups. On multivariable analysis, only multifocality, early recurrence, and failure of intravesical therapy independently predicted oncological outcomes. Using these factors, patients were stratified as IR‐low (no factors), IR‐intermediate (one factor), or IR‐high (two or more factors). Under the simplified model, 1535 (54%) patients were classified as IR‐low, 906 (32%) as IR‐intermediate, and 381 (14%) as IR‐high. The 3‐year recurrence and progression rates increased stepwise across simplified risk groups. Discriminative performance of the simplified model was comparable to the full model across all metrics, with no meaningful loss of discrimination.

Conclusion

Three variables captured the most prognostic signal in this cohort without loss of discrimination compared with the full model. This simplified model is an internally validated refinement, with planned external validation to confirm generalisability and to ensure that simplified thresholds do not alter the clinically important IR‐high subgroup used in care and trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-Muscle Invasive Bladder NeoplasmsUrinary Bladder NeoplasmsHumansRetrospective StudiesFemaleMaleAgedTransurethral Resection of BladderRisk AssessmentNeoplasm Recurrence, LocalMiddle AgedPrognosisDisease ProgressionAdministration, IntravesicalAged, 80 and over

Stichwörter der Autor:innen

IBCGNMIBCbladder cancernon‐muscle‐invasive bladder cancerurothelial cancer

Autor:innen und Institutionen

  • Department of Urology, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Urology, University of Kentucky College of Medicine, Lexington, KY, USA.
  • Department of Pathology, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

ORCID-Profile: Can Aydogdu, Nicholas Heller

Zitieren

APA

Siva, J., Aydogdu, C., Heller, N., Jonnalagadda, R., Hensley, P. J., Diaz, G. M., McSweeney, S., Campbell, R., Almassi, N., Alaghehbandan, R., Weight, C. J., Kamat, A. M., & Bukavina, L. (2026). Reducing complexity in International Bladder Cancer Group intermediate‐risk non‐muscle‐invasive bladder cancer stratification: a three‐factor approach. BJU International, 138(2), 244-249. https://doi.org/10.1111/bju.70269

Vancouver

Siva J, Aydogdu C, Heller N, Jonnalagadda R, Hensley PJ, Diaz GM, et al. Reducing complexity in International Bladder Cancer Group intermediate‐risk non‐muscle‐invasive bladder cancer stratification: a three‐factor approach. BJU International. 2026;138(2):244-249. doi:10.1111/bju.70269

BibTeX
@article{Siva2026,
  author = {Siva, Jayant and Aydogdu, Can and Heller, Nicholas and Jonnalagadda, Rishi and Hensley, Patrick J and Diaz, Gabriela M and McSweeney, Sean and Campbell, Rebecca and Almassi, Nima and Alaghehbandan, Reza and Weight, Christopher J and Kamat, Ashish M and Bukavina, Laura},
  title = {Reducing complexity in International Bladder Cancer Group intermediate‐risk non‐muscle‐invasive bladder cancer stratification: a three‐factor approach},
  journal = {BJU International},
  year = {2026},
  volume = {138},
  number = {2},
  pages = {244--249},
  doi = {10.1111/bju.70269}
}
Kostenlos starten →